Cargando…
Ocoxin Increases the Antitumor Effect of BRAF Inhibition and Reduces Cancer Associated Fibroblast-Mediated Chemoresistance and Protumoral Activity in Metastatic Melanoma
Whereas the prevalence of several cancer types is decreasing, skin malignancies are growing more common every year. Malignant melanoma is the most aggressive form of skin cancer with high metastatic capacity. In most cases, malignant melanoma shows acquired therapy resistance. We evaluated the abili...
Autores principales: | Benedicto, Aitor, Hernandez-Unzueta, Iera, Sanz, Eduardo, Márquez, Joana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924874/ https://www.ncbi.nlm.nih.gov/pubmed/33669949 http://dx.doi.org/10.3390/nu13020686 |
Ejemplares similares
-
Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance
por: Hernandez-Unzueta, Iera, et al.
Publicado: (2019) -
Improving the Antitumor Effect of Chemotherapy with Ocoxin as a Novel Adjuvant Agent to Treat Prostate Cancer
por: Hernandez-Unzueta, Iera, et al.
Publicado: (2023) -
Ocoxin oral solution(®) as a complement to irinotecan chemotherapy in the metastatic progression of colorectal cancer to the liver
por: Hernandez-Unzueta, Iera, et al.
Publicado: (2017) -
Ocoxin(®) oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb/c mice
por: MÁRQUEZ, JOANA, et al.
Publicado: (2016) -
Ocoxin as a complement to first line treatments in cancer
por: Benedicto, Aitor, et al.
Publicado: (2021)